Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Senmiao Technology Q3 EPS $(0.13)

Senmiao Technology Q3 EPS $(0.13)

Senmiao Technology (NASDAQ:AIHS) reported quarterly losses of $(0.13) per share.

byMichael Horton

February 14, 2023

1 minute read

Senmiao Technology (NASDAQ:AIHS) reported quarterly losses of $(0.13) per share.

Citigroup Maintains Buy on Capri Holdings, Raises Price Target to $75

By Benzinga Newsdesk

January 31, 7:52 AM

Citigroup analyst Paul Lejuez maintains Capri Holdings (NYSE:CPRI) with a Buy and raises the price target from $67 to $75.

CPRI

Lumos Pharma Says Growth Hormone Deficiency Trial Meet Expectations

By Vandana Singh

November 14, 1:29 PM

Lumos Pharma Inc (NASDAQ:LUMO) announced interim results from its Phase 2 OraGrowtH210 Trial and Phase 2 Pharmacokinetic/Pharmacodynamic (PK/PD) OraGrowtH212 Trial of…

LUMO

Blink Charging Adopts North America Charging Standard Into Entire Product Line

By Shivani Kumaresan

June 28, 11:45 AM

Blink Charging Co (NASDAQ: BLNK) plans to

BLNK

Maravai LifeSciences Lowers FY2022 Adj EPS Guidance from $1.74-1.90 to $1.70-1.80; Lowers FY2022 Sales Guidance from $920.00M-960.00M to $880.00M-910.00M

By Benzinga Newsdesk

August 4, 4:29 PM

Maravai LifeSciences (NASDAQ:MRVI) lowers FY2022 Adj EPS guidance from $1.74-1.90 to $1.70-1.80. Lowers FY2022 sales outlook from $920.00 million-960.00 million to $880.00 million-910.00 million.

MRVI

Senmiao Technology Q3 EPS $(0.13)

Related Posts

Citigroup Maintains Buy on Capri Holdings, Raises Price Target to $75

Lumos Pharma Says Growth Hormone Deficiency Trial Meet Expectations

Blink Charging Adopts North America Charging Standard Into Entire Product Line

Maravai LifeSciences Lowers FY2022 Adj EPS Guidance from $1.74-1.90 to $1.70-1.80; Lowers FY2022 Sales Guidance from $920.00M-960.00M to $880.00M-910.00M